Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai BasalMedia Technologies is a specialized provider of high-performance cell culture media and bioprocessing solutions for the global life sciences industry. Founded in 2013, the company focuses on the R&D and large-scale manufacturing of serum-free, chemically defined media tailored for various cell lines such as CHO, HEK293, and insect cells. Their products are widely utilized in the production of monoclonal antibodies, vaccines, and recombinant proteins. BasalMedia also offers comprehensive media optimization services and technical support to enhance biopharmaceutical manufacturing efficiency. The company operates state-of-the-art GMP manufacturing facilities to ensure high-quality standards and regulatory compliance for international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BasalMedia.